MIRA Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.64	2.83	4.6	0.35	2.81	0
Short-Term Investments	4.89	-	-	-	-	-
Cash & Short-Term Investments	7.54	2.83	4.6	0.35	2.81	0
Cash Growth	81.83%	-38.45%	1211.36%	-87.51%	80379.86%	-
Other Receivables	0.04	0.04	0.08	-	0.45	0.02
Total Trade Receivables	0.04	0.04	0.08	-	0.45	0.02
Other Current Assets	0.06	0.05	0.24	0.14	0.1	-
Total Current Assets	7.6	2.89	4.86	0.49	2.91	0
Net Property, Plant & Equipment	-	-	0.01	0.36	-	-
Total Assets	7.63	2.92	4.93	0.86	3.36	0.02
Accounts Payable	0.08	0.42	0.54	0.93	0.78	-
Accrued Expenses	-	0.3	0.01	0.03	0.02	0
Short-Term Debt	-	-	-	0.13	0.29	0.09
Current Portion of Leases	-	-	0.01	0.27	-	-
Total Current Liabilities	0.08	0.72	0.56	1.37	1.09	0.09
Long-Term Leases	-	-	-	0.08	-	-
Total Long-Term Liabilities	-	-	-	0.08	-	-
Total Liabilities	0.08	0.72	0.56	1.45	1.09	0.09
Common Stock	0	0	0	0.01	0.01	0.01
Treasury Stock	-	-	-	-	-	-0.01
Additional Paid-in Capital	41.14	31.34	25.66	8.7	4.5	-
Retained Earnings	-33.6	-29.14	-21.29	-9.3	-2.24	-0.07
Shareholders' Equity	7.55	2.2	4.37	-0.6	2.26	-0.07
Total Liabilities & Equity	7.63	2.92	4.93	0.86	3.36	0.02
Total Debt	-	0	0.01	0.49	0.29	0.09
Net Cash (Debt)	7.54	2.83	4.6	-0.14	2.52	-0.09
Net Cash Growth	166.01%	-38.38%	-	-	-	-
Net Cash Per Share	0.43	0.18	0.33	-0.01	-	-
Book Value	7.55	2.2	4.37	-0.6	2.26	-0.07
Book Value Per Share	0.43	0.14	0.31	-0.03	-	-
Tangible Book Value	7.55	2.2	4.37	-0.6	2.26	-0.07
Tangible Book Value Per Share	0.43	0.14	0.31	-0.03	-	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q